Inhibikase Therapeutics (IKT)
Nasdaq • IKT • US45719W2052
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 24.3% of free float sold short, 29.4 days to cover, cost to borrow 1.06%. Sign up for live short interest data.
Market Cap
326m USD | # 6704 in US
Volume
559.73k shares | 1.15m USD
Shares Outstanding
139.54m
Free Float Shares
58.82% | 82.07m
